Javier
Arbizu Lostao
Consultor Médico
Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas
Madrid, EspañaPublications en collaboration avec des chercheurs de Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (8)
2019
-
Plasma Aβ42/40 ratio alone or combined with FDG-PET can accurately predict amyloid-PET positivity: A cross-sectional analysis from the AB255 Study
Alzheimer's Research and Therapy, Vol. 11, Núm. 1
2014
-
Grey matter hypometabolism and atrophy in Parkinson's disease with cognitive impairment: A two-step process
Brain, Vol. 137, Núm. 8, pp. 2356-2367
2012
-
Decreased carbon-11-flumazenil binding in early Alzheimer's disease
Brain, Vol. 135, Núm. 9, pp. 2817-2825
-
Usefulness of positron emission tomography with fludeoxyglucose F 18 and with carbon 11-tagged methionine in the diagnosis of hippocampal lesions
Archives of Neurology, Vol. 69, Núm. 12, pp. 1652-1653
2010
-
Brain glucose metabolism in vascular white matter disease with dementia: Differentiation from Alzheimer disease
Stroke, Vol. 41, Núm. 12, pp. 2889-2893
-
Neuroimagen: Fundamentos técnicos y prácticos
Revista Espanola de Medicina Nuclear, Vol. 29, Núm. 4, pp. 189-210
2009
-
New MRI, 18F-DOPA and 11C-(+)-α-dihydrotetrabenazine templates for Macaca fascicularis neuroimaging: Advantages to improve PET quantification
NeuroImage, Vol. 47, Núm. 2, pp. 533-539
2008
-
Successful thalamic deep brain stimulation for orthostatic tremor
Movement Disorders, Vol. 23, Núm. 13, pp. 1808-1811